Moreover, they developed a PDE10A-suppressed GBM model using the RCAS/tv-a system in mice, which caused an aggressive glioma phenotype, promoted a proneural-to-mesenchymal transition, and increased resistance to chemo- and radiotherapy. This evidence concerns the gene PDE10A and central nervous system cancer.